(Q40903047)

24 September 2017

1 reference

title

Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments (English)

1 reference

24 September 2017

1 reference

Choy EH

1

1 reference

24 September 2017

Scott DL

series ordinal

2

1 reference

24 September 2017

publication date

1 March 1997

1 reference

24 September 2017

1 reference

24 September 2017

volume

53

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

337-348

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753030-00001

24 September 2017

exact match

0 references

cites work

NSAID gastropathy. A new understanding

1 reference

12 December 2020

The value of C-reactive protein measurement in rheumatoid arthritis

1 reference

12 December 2020

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

1 reference

12 December 2020

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

1 reference

12 December 2020

Effects of oral administration of type II collagen on rheumatoid arthritis

1 reference

12 December 2020

Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis

1 reference

12 December 2020

Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate

1 reference

12 December 2020

Nabumetone: a "nonacidic" nonsteroidal antiinflammatory drug

1 reference

12 December 2020

Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected?

1 reference

12 December 2020

Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases.

1 reference

12 December 2020

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

12 December 2020

Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs?

1 reference

12 December 2020

Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study

1 reference

12 December 2020

The relationship between serial measures of disease activity and outcome in rheumatoid arthritis

1 reference

12 December 2020

Treatment of early rheumatoid arthritis with rifampicin

1 reference

12 December 2020

Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis

1 reference

12 December 2020

Intravenous immunoglobulin therapy for rheumatic diseases.

1 reference

12 December 2020

The treatment of osteoarthritis

1 reference

12 December 2020

A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.

1 reference

12 December 2020

A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen

1 reference

12 December 2020

Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat

1 reference

12 December 2020

Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update

1 reference

12 December 2020

Misoprostol in the prevention of gastroduodenal damage in rheumatology

1 reference

12 December 2020

Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis

1 reference

12 December 2020

Minocycline treatment of rheumatoid arthritis

1 reference

12 December 2020

Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

1 reference

12 December 2020

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

12 December 2020

New classification of antirheumatic drugs. The evolution of a concept

1 reference

12 December 2020

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Long-term experience with low dose methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis

1 reference

12 December 2020

Cyclosporin A in rheumatoid arthritis: overview of efficacy

1 reference

12 December 2020

Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?

1 reference

12 December 2020

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

1 reference

12 December 2020

Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens

1 reference

12 December 2020

Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data

1 reference

12 December 2020

NSAIDs in the treatment of osteoarthritis. Friends or foes?

1 reference

12 December 2020

Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group

1 reference

12 December 2020

Antirheumatic drugs: a proposed new classification

1 reference

12 December 2020

A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis

1 reference

12 December 2020

Effects of leflunomide on immune responses and models of inflammation

1 reference

12 December 2020

Minocycline treatment for rheumatoid arthritis: an open dose finding study

1 reference

12 December 2020

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis

1 reference

12 December 2020

Treatment of resistant rheumatoid arthritis with minocycline: an open study

1 reference

12 December 2020

High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis

1 reference

12 December 2020

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

12 December 2020

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

12 December 2020

Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial

1 reference

12 December 2020

Refractory rheumatoid arthritis. Therapeutic options

1 reference

12 December 2020

n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis

1 reference

12 December 2020

Early, aggressive therapy for rheumatoid arthritis: concerns, descriptions, and estimate of outcome

1 reference

12 December 2020

Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response

1 reference

12 December 2020

Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis

1 reference

12 December 2020

OMERACT, Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Proceedings. Maastricht, The Netherlands, April 29-May 3, 1992

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

New insights into the mode of action of anti-inflammatory drugs.

1 reference

12 December 2020

Rifampicin in early rheumatoid arthritis

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts

1 reference

12 December 2020

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

12 December 2020

Rifampicin in rheumatoid arthritis

1 reference

12 December 2020

Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings

1 reference

12 December 2020

Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy

1 reference

12 December 2020

Osteoarthritis in the aged. Epidemiological issues and optimal management.

1 reference

12 December 2020

Nabumetone: a clinical appraisal

1 reference

12 December 2020

Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin a

1 reference

12 December 2020

Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis

1 reference

12 December 2020

Clinical and laboratory assessment of outcome in rheumatoid arthritis

1 reference

12 December 2020

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1 reference

12 December 2020

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

12 December 2020

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

12 December 2020

A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity

1 reference

12 December 2020

The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol

1 reference

12 December 2020

Therapeutic strategies distinguish community based primary care physicians from rheumatologists in the management of osteoarthritis

1 reference

12 December 2020

Deflazacort. A review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Potency ratio--a brief synopsis

1 reference

12 December 2020

Intravenous immunoglobulin therapy: magic or black magic

1 reference

12 December 2020

Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial

1 reference

12 December 2020

Cyclosporin in rheumatoid arthritis.

1 reference

12 December 2020

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

1 reference

12 December 2020

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

1 reference

12 December 2020

Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone

1 reference

12 December 2020

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

1 reference

12 December 2020

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

12 December 2020

10.2165/00003495-199753030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1050840707

0 references

1 reference